Eiger Biopharmaceuticals's activity chart (see below) currently has 51 price targets and 39 ratings on display.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 27-Apr-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2019
$120
3 years 2 months 24 days ago
(29-Aug-2023)
0/4 (0%)
$81.6 (212.50%)
Buy Since 09-May-2018
$150
3 years 4 months 23 days ago
(30-Jun-2023)
0/2 (0%)
$128.88 (610.23%)
Buy Since 09-Dec-2022
$90
$90
3 years 6 months 7 days ago
(15-May-2023)
0/2 (0%)
$52.2 (138.10%)
Buy Since 14-Jul-2017
$270
$1440
3 years 11 months 10 days ago
(12-Dec-2022)
0/5 (0%)
$231.6 (603.13%)
Buy Since 19-Oct-2017
$870
$690
4 years 8 months 5 days ago
(17-Mar-2022)
0/4 (0%)
$630.6 (263.41%)
Which analyst most recently updated their price target on EIGR (Eiger Biopharmaceuticals)?
Which analyst has the most public recommendations on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most bullish on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most reserved on EIGR (Eiger Biopharmaceuticals)?